12:00 AM
 | 
Jul 23, 2012
 |  BC Week In Review  |  Company News  |  Deals

BioNTech, Crelux, 4SC deal

4SC's 4SC Discovery GmbH subsidiary, Crelux and BioNTech's Ribological GmbH subsidiary partnered to identify and optimize compounds to be used with RNA molecules from Ribological in cancer...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >